Attana at the Antibody Engineering & Design (AED) Conference 2011

Event date 21 February 2011 – 24 February 2011

Location InterCity Hotel, Frankfurt

Join our panel discussion- Wed 23rd @ 16.40 Biologically relevant information- improving success of clinical trials! Panelists: Dr Teodor Aastrup, CEO, Attana Dr Juan Carlos Almagro, Research Fellow, Head, Antibody Design Unit, Centocor Dr Jesus Zurdo, Head of Innovation LCM Development Services, Lonza Dr Alain Beck, Head of Physico Chemistry, Centre d'Immunologie Pierre Fabre The panel discussion will be introduced with a presentation by Dr Jesus Zurdo, Head of Innovation LCM Development Services with Lonza on Managing development risks in biopharmaceuticals through lead optimisation and early analytical tools at 16.20. The AED Conference is dedicated to accelerating the development of therapeutic antibodies through engineering approaches.

Categories

  • teodor aastrup
  • attana
  • antibody engineering and design
  • biologically relevant infomation
  • attana 200
  • biotech

Related content